Possible Association of CD68 Positive Macrophages with Some other Prognostic Factors (ki67, ER, PR, Her2 neu) in Primary Breast Cancer and Axillary Lymph Node Metastasis

Authors

  • Bahram Pourseyedi Associate Professor of Surgery, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
  • Hakime Khalili Resident, Pathology and Stem Cells Research Center& Pathology Department, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
  • Hamid Zeinalinejad Associate Professor of Surgery, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
  • Shahriar Dabiri Professor of Pathology, Afzalipour School of Medicine &Pathology and Stem Cells Research Center, Kerman University of Medical Sciences, Kerman, Iran
Abstract:

Background: Breast cancer is formed of a neoplastic component (epithelial) and a non-neoplastic component (stroma). Stromal- stromal and tumor- stromal interactions have been shown in the regulation of cancer cell growth, metastatic capacity and outcome of treatment. Tumor-associated macrophages (TAMs) are a component of tumor stroma reactionsand are considered as an important component of breast cancer tumor tissue which approximately form 50 % to 80 % of tumor tissue.In this study, the frequency of CD68 positive cells in association with other factors such as age, tumor size, ER, PR, Ki-67, Her2-neu receptors, stage and grade in invasive carcinoma tissues were morphologically and statistically evaluated. The frequency of CD68 was also discussed in relation to the number of involved lymph nodes. Method: A total of 50 invasive breast cancer patients with and without axillary lymph nodes involvement were studied. IHC staining for CD68 and Ki-67 markers was performed. For each tumor, 5 fields with different density of CD68 were counted under 400x by optical microscopy and the average of the five fields was taken as the percentage. Patients were divided into the two groups of low infiltration and high infiltration based on the percentage of CD68.By the same way, patients were divided into the two groups of low infiltration and high infiltration based on Ki67 percentage. Results: CD68 positive cells had significant correlation with ER negative and higher Ki67. No significant correlation was found between CD68 positive cells and the number of involved lymph nodes, age, size, HER2neu, PR, stage and grade. Conclusion: It seems that the presence of CD68 -positive macrophages in invasive breast cancers and nearby lymph nodes is associated with a worse prognosis.  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Correlation of ER, PR and HER-2/Neu with other Prognostic Factors in Infiltrating Ductal Carcinoma of Breast

Background and Objectives: Breast cancer is the most common malignancy among women in the world. The aim of this study was to assess estrogen receptor (ER), progesterone receptor (PR) and HER-2/neu of infiltrating ductal carcinoma (IDC) with tumor size, histologic grade, lymph node metastasis and age. Methods: This study was carried out on 300 tissue blocks ofpatients with ID...

full text

Lymphovascular Invasion and HER2/neu Amplification as Predictive Factors for Axillary Lymph Node Metastasis in Early Breast Cancer Patients

negative axilla. The American Society of Clinical Oncology Purpose: Axillary lymph node metastasis (ALNM) can occur even in breast cancer smaller than 2 cm in size. This study was performed to investigate the clinicopathologic factors that affect node metastasis in T1 breast cancer. Methods: We reviewed the medical record of 206 T1 breast cancer patients and we divided them into two groups acco...

full text

Potential role of hsa_circ_0003098 circular RNA in breast cancer and its association with demographic factors and lymph node metastasis

Background and Objectives: A growing amount of evidence has revealed that circular RNAs (circRNAs), covalently closed single-stranded non-coding RNAs (ncRNAs), play significant roles in initiation and progression of breast cancer (BC) through different mechanisms.  This study aims to investigate the hsa_circ_0003098 expression and its potential roles in BC, as well as the circRNA/miRNA/mRNA cro...

full text

Relationship between NF-κB, ER, PR, Her2/neu, Ki67, p53 expression in human breast cancer.

AIM The aim of the present study was to investigate expression patterns of transcription factor NF-κB (p50 and p65), ER, PR, Her2/neu, Ki-67 and p53 in tumor tissue of patients with breast cancer (BC) and analyze correlation between these markers. PATIENTS AND METHODS 62 BC patients previously not treated with chemo- or radiotherapy were included in the study. All tumors belong to invasive du...

full text

Factors influencing axillary lymph node metastasis in invasive breast cancer.

PURPOSE To explore the relationship between auxiliary lymph node metastasis and clinical features, and to identify the factors that affect metastasis occurrence. METHODS A total of 164 cases of primary breast cancer were selected to investigate features such as age, concomitant chronic disease and pathologic diagnosis. Immunohistochemistry was used to detect the expression of the estrogen rec...

full text

Correlation of Breast Cancer Subtypes Based on ER, PR and HER2 Expression with Axillary Lymph Node Status

Background:Lymph node metastasis is the most important prognostic factor in breast cancer patients. The present study was carried out to evaluate the association between ER, PR and HER-2/neu expression status, separately and in combinations with axillary lymph node involvement. Patients and methods: Two hundred and fifty eight breast cancer patients treated with modified radical mastectomy with...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 24  issue 6

pages  459- 466

publication date 2017-11-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023